Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung Microbiome Differentially Impacts Survival of Patients with Non-Small Cell Lung Cancer Depending on Tumor Stroma Phenotype
О. В. Ковалева, P. A. Podlesnaya, M. A. Rashidova, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 349-349
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Lung microbiome: new insights into the pathogenesis of respiratory diseases
Ruomeng Li, Jing Li, Xikun Zhou
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 112
Tumor microbiome – an integral part of the tumor microenvironment
Sona Ciernikova, Aneta Sevcikova, Viola Stevurkova, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 40
Potential links between the microbiota and T cell immunity determine the tumor cell fate
Amir Hossein Mohseni, Sedigheh Taghinezhad‐S, Vincenzo Casolaro, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 24
Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer
Haiming Chen, Yi Ma, Juqing Xu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101499-101499
Open Access | Times Cited: 12
The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer
Brandilyn A. Peters, Harvey I. Pass, Robert D. Burk, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 30
The impact of concurrent bacterial lung infection on immunotherapy in patients with non-small cell lung cancer: a retrospective cohort study
Qiang Cao, Xinyan Wu, Yuquan Chen, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 21
Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients
Shuyue Zhang, Shuishen Zhang, Xiaofan Ma, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 17
Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected
Jiuling Cheng, Lujia Zhou, Huaqi Wang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 7
The composition of lung microbiome in lung cancer: a systematic review and meta-analysis
Sadaf Najafi, Fatemeh Abedini, Sadegh Azimzadeh Jamalkandi, et al.
BMC Microbiology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 39
The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity
Mai Anh Huynh, Meredith J. Crane, A. M. Jamieson
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
Distinct respiratory microbiota associates with lung cancer clinicopathological characteristics
Xi Zheng, Xingbing Lu, Yang Hu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Unravelling the prognostic and operative role of intratumoural microbiota in non‐small cell lung cancer: Insights from 16S rRNA and RNA sequencing
Fuling Mao, Zixuan Hu, Ruifeng Shi, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
The Current Roadmap of Lung Cancer Biology, Genomics and Racial Disparity
Enas S. Alsatari, Kelly R. Smith, Sampath Rukshani Galappaththi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3818-3818
Open Access
The microbiome of lung cancer tissue and its association with pathological and clinical parameters.
Ock‐Hwa Kim, Bo-Yun Choi, Dong Kwan Kim, et al.
PubMed (2022) Vol. 12, Iss. 5, pp. 2350-2362
Closed Access | Times Cited: 18
Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients’ Survival: A Pilot Study
О. В. Ковалева, P. A. Podlesnaya, Maxim Sorokin, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1516-1516
Open Access | Times Cited: 17
Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy
Jingtao Zhang, Shuai Liu, Xiubao Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115336-115336
Open Access | Times Cited: 8
Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives
Claudia Lombardo, Rosario Fazio, Marta Sinagra, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 11, pp. 1083-1083
Open Access | Times Cited: 2
Composition of the sputum bacterial microbiome of patients with different pathomorphological forms of non-small-cell lung cancer
В. Г. Дружинин, Elizaveta Baranova, П. С. Деменков, et al.
Vavilov Journal of Genetics and Breeding (2024) Vol. 28, Iss. 2, pp. 204-214
Open Access | Times Cited: 2
Prognostic Significance of the Microbiome and Stromal Cells Phenotype in Esophagus Squamous Cell Carcinoma
О. В. Ковалева, P. A. Podlesnaya, M. A. Rashidova, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 743-743
Open Access | Times Cited: 14
Species Diversity and Network Diversity in the Human Lung Cancer Tissue Microbiomes
Yuting Qiao, Jiandong Mei, Zhanshan Ma
FEMS Microbiology Letters (2024) Vol. 371
Closed Access | Times Cited: 1
CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer
О. В. Ковалева, M. A. Rashidova, Daria V. Samoilova, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 450-450
Open Access | Times Cited: 9
De- “bug”-ing the microbiome in lung cancer
Pakhi Birla, Fyza Y. Shaikh
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 2, pp. 335-346
Closed Access | Times Cited: 6
Microbial Biomarkers for Lung Cancer: Current Understandings and Limitations
Jiawen Huang, Juan Huang
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7298-7298
Open Access | Times Cited: 5
Exploring Co-occurrence patterns and microbial diversity in the lung microbiome of patients with non-small cell lung cancer
Sadaf Najafi, Sadegh Azimzadeh Jamalkandi, Ali Najafi, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer
Mark Klein, Alexa A. Pragman, Christine Wendt
Seminars in Oncology (2022) Vol. 49, Iss. 3-4, pp. 285-297
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top